Evidence map›Paper›PMID 36268112›Full record

ArticleWeb semantics (Online)2023

Knowledge4COVID-19: A semantic-based approach for constructing a COVID-19 related knowledge graph from various sources and analyzing treatments' toxicities.

Ahmad Sakor, Samaneh Jozashoori, Emetis Niazmand, Ariam Rivas, Konstantinos Bougiatiotis, Fotis Aisopos, Enrique Iglesias, Philipp D Rohde, Trupti Padiya, Anastasia Krithara and 2 more

Abstract read
In one paragraph

Article in Web semantics (Online), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ahmad SakorTIB Leibniz Information Centre for Science and Technology, Welfengarten 1 B, Hannover, Germany.
Samaneh JozashooriTIB Leibniz Information Centre for Science and Technology, Welfengarten 1 B, Hannover, Germany.
Emetis NiazmandTIB Leibniz Information Centre for Science and Technology, Welfengarten 1 B, Hannover, Germany.
Ariam RivasTIB Leibniz Information Centre for Science and Technology, Welfengarten 1 B, Hannover, Germany.
Konstantinos BougiatiotisInstitute of Informatics & Telecommunications, NCSR Demokritos, Patr. Grigoriou & Neapoleos Str, Ag. Paraskevi, Athens, Greece.
Fotis AisoposInstitute of Informatics & Telecommunications, NCSR Demokritos, Patr. Grigoriou & Neapoleos Str, Ag. Paraskevi, Athens, Greece.
Enrique IglesiasTIB Leibniz Information Centre for Science and Technology, Welfengarten 1 B, Hannover, Germany.
Philipp D RohdeTIB Leibniz Information Centre for Science and Technology, Welfengarten 1 B, Hannover, Germany.
Trupti PadiyaTIB Leibniz Information Centre for Science and Technology, Welfengarten 1 B, Hannover, Germany.
Anastasia KritharaInstitute of Informatics & Telecommunications, NCSR Demokritos, Patr. Grigoriou & Neapoleos Str, Ag. Paraskevi, Athens, Greece.
Georgios PaliourasInstitute of Informatics & Telecommunications, NCSR Demokritos, Patr. Grigoriou & Neapoleos Str, Ag. Paraskevi, Athens, Greece.
Maria-Esther VidalTIB Leibniz Information Centre for Science and Technology, Welfengarten 1 B, Hannover, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, we present Knowledge4COVID-19, a framework that aims to showcase the power of integrating disparate sources of knowledge to discover adverse drug effects caused by drug-drug interactions among COVID-19 treatments and pre-existing condition drugs. Initially, we focus on constructing the Knowledge4COVID-19 knowledge graph (KG) from the declarative definition of mapping rules using the RDF Mapping Language. Since valuable information about drug treatments, drug-drug interactions, and side effects is present in textual descriptions in scientific databases (e.g., DrugBank) or in scientific literature (e.g., the CORD-19, the Covid-19 Open Research Dataset), the Knowledge4COVID-19 framework implements Natural Language Processing. The Knowledge4COVID-19 framework extracts relevant entities and predicates that enable the fine-grained description of COVID-19 treatments and the potential adverse events that may occur when these treatments are combined with treatments of common comorbidities, e.g., hypertension, diabetes, or asthma. Moreover, on top of the KG, several techniques for the discovery and prediction of interactions and potential adverse effects of drugs have been developed with the aim of suggesting more accurate treatments for treating the virus. We provide services to traverse the KG and visualize the effects that a group of drugs may have on a treatment outcome. Knowledge4COVID-19 was part of the Pan-European

Indexed as

00-0199-00COVID-19Drug–drug interactionsKnowledge graphs

Identifiers

PMID36268112
PMCPMC9558693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.